Healenz-D Tablet is a combination pharmaceutical formulation containing Trypsin (48mg), Bromelain (90mg), Rutoside (100mg), and Diclofenac (50mg), designed to provide effective anti-inflammatory, analgesic, and fibrinolytic effects. Trypsin and Bromelain are proteolytic enzymes that aid in the reduction of edema and inflammation by promoting the breakdown of proteins involved in inflammatory processes, thereby facilitating faster tissue repair. Rutoside, a bioflavonoid, exhibits antioxidant properties and strengthens capillary walls, reducing capillary permeability and fragility, which helps in minimizing bruising and swelling. Diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), provides potent analgesic and anti-inflammatory action by inhibiting cyclooxygenase enzymes, thus decreasing prostaglandin synthesis responsible for pain and inflammation. The synergistic action of these components makes Healenz-D Tablet particularly effective in managing acute musculoskeletal conditions such as sprains, strains, contusions, and post-operative inflammation. It is also beneficial in chronic inflammatory disorders requiring combined enzyme and NSAID therapy. Healenz-D should be used under medical supervision, considering contraindications such as hypersensitivity to NSAIDs, peptic ulcer disease, and bleeding disorders. Proper dosage and duration should be adhered to in order to optimize therapeutic outcomes while minimizing adverse effects.